UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2022	Jun. 30, 2021
Total revenue	$ 588.4	$ 570.8	$ 1,183.4	$ 1,125.5
Total cost of revenue	290.2	290.2	578.9	566.2
Gross profit	298.2	280.6	604.5	559.3
Operating expenses:
Selling, general and administrative	152.2	134.8	297.9	266.6
Research and development	59.6	55.8	116.2	110.6
Other charges, net	12.5	4.4	20.0	7.4
Total operating expenses	224.3	195.0	434.1	384.6
Operating income	73.9	85.6	170.4	174.7
Interest and other income (expense), net	(4.3)	(5.6)	(6.8)	(9.4)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	69.6	80.0	163.6	165.3
Income tax provision	19.9	21.3	51.8	48.8
Consolidated net income	49.7	58.7	111.8	116.5
Net income attributable to noncontrolling interests in consolidated subsidiaries	0.2	1.1	0.7	2.2
Net income attributable to Bruker Corporation	$ 49.5	$ 57.6	$ 111.1	$ 114.3
Net income per common share attributable to Bruker Corporation shareholders:
Basic	$ 0.33	$ 0.38	$ 0.74	$ 0.75
Diluted	$ 0.33	$ 0.38	$ 0.74	$ 0.75
Weighted average common shares outstanding:
Basic (in shares)	149.0	151.3	149.7	151.6
Diluted (in shares)	149.8	152.9	150.6	153.0
Comprehensive income	$ 15.9	$ 73.4	$ 69.1	$ 115.0
Less: Comprehensive income (loss) attributable to noncontrolling interests	(0.4)	(0.7)	(0.2)	0.2
Less: Comprehensive loss attributable to redeemable noncontrolling interest	(0.5)	0.0	(0.7)	0.0
Comprehensive income attributable to Bruker Corporation	16.8	74.1	70.0	114.8
Product
Total revenue	485.8	474.3	976.2	932.9
Total cost of revenue	230.1	236.0	459.1	456.9
Service
Total revenue	100.9	94.7	204.1	188.8
Total cost of revenue	60.1	54.1	119.7	108.8
Other
Total revenue	1.7	1.8	3.1	3.8
Total cost of revenue	$ 0.0	$ 0.1	$ 0.1	$ 0.5